| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/08/1995 | EP0439555B1 Oligosaccharides having antiatherosclerotic activity |
| 03/08/1995 | CN1099759A 哌嗪衍生物 Piperazine derivatives |
| 03/08/1995 | CN1099755A Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/08/1995 | CN1099648A Traditional Chinese medicine for curing bleeding disease and preparing method |
| 03/08/1995 | CA2130864A1 Carboxamides |
| 03/07/1995 | US5395950 Production of quinic acid derivatives |
| 03/07/1995 | US5395828 Cardiovascular |
| 03/02/1995 | WO1995006068A1 Novel polysaccharide and radioprotective agent containing the same as active ingredient |
| 03/02/1995 | WO1995006038A1 Platelet aggregation inhibitors |
| 03/02/1995 | CA2168345A1 Phenylamidine derivatives as platelet aggregation inhibitors |
| 03/01/1995 | EP0640619A1 Erythropoietin analogs with additional glycosylation sites |
| 03/01/1995 | EP0640599A1 4-Aminopyrimidine derivatives |
| 03/01/1995 | EP0640100A1 Modulation of thrombospondin-cd36 interactions |
| 03/01/1995 | EP0640086A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO 1,2]PYRIDAZINE, PYRAZOLO 1,2]PYRIDAZINE, PYRIDAZO 1,2-a] 1,2]DIAZEPINE AND PYRAZOLO 1,2-a] 1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
| 03/01/1995 | EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 03/01/1995 | EP0462264B1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists |
| 03/01/1995 | EP0406428B1 Peptide derivatives and their use |
| 02/28/1995 | US5393873 Peptides with anticoagulant activity |
| 02/28/1995 | US5393760 Guanidine derivatives |
| 02/28/1995 | US5393740 Neurotensin Hexapeptides |
| 02/27/1995 | CA2130793A1 Heterocyclic thrombin inhibitors |
| 02/23/1995 | WO1995005465A1 Erythropoietin analogs |
| 02/23/1995 | WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 02/23/1995 | WO1995005397A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | WO1995005393A2 Lipopolysaccharide-binding and neutralizing peptides |
| 02/23/1995 | WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | WO1995005358A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect |
| 02/23/1995 | CA2169280A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | CA2169187A1 Use of phenols and phenol derivatives as pharmaceutical agents with a fibrinogen-lowering action |
| 02/23/1995 | CA2169178A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | CA2146667A1 Lipopolysaccharide-binding and neutralizing peptides |
| 02/22/1995 | EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production |
| 02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 02/22/1995 | EP0639202A1 Stable polypeptide composition |
| 02/22/1995 | CN1099038A 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them |
| 02/21/1995 | US5391556 Thrombin inhibitors |
| 02/21/1995 | US5391380 Used in blood coagulation tests; mixed with metal ion chelator |
| 02/21/1995 | CA1334516C Process for preparing high-purity dermatan sulphate, and pharmaceutical compositions which contain it |
| 02/16/1995 | WO1995004823A1 High molecular weight desulphatohirudin |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004531A1 Fibrinogen receptor antagonists |
| 02/16/1995 | CA2168581A1 Fibrinogen receptor antagonists |
| 02/16/1995 | CA2144523A1 High molecular weight desulphatohirudin |
| 02/15/1995 | EP0638553A1 Carboxylic acid amides having a terminal carboxylic acid group as aggregation inhibiting drugs |
| 02/15/1995 | EP0638314A1 Process for producing plasminogen-containing composition |
| 02/15/1995 | EP0638088A1 Hybrid human/porcine factor viii |
| 02/15/1995 | EP0524172B1 A method for isolating factor viii |
| 02/14/1995 | US5389666 Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
| 02/14/1995 | US5389655 Treats angina pectoris |
| 02/14/1995 | US5389633 Triazolopyridazine compounds, their production and use |
| 02/14/1995 | US5389631 Fibrinogen receptor antagonists |
| 02/14/1995 | US5389618 Having bioavailability and antithrombotic activity greater than heparin |
| 02/14/1995 | US5389614 Anticoagulants |
| 02/14/1995 | CA1334470C Antithrombogenic and antibiotic compositions and methods of preparation thereof |
| 02/09/1995 | WO1995004075A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | WO1995004057A1 TRICYCLIC INHIBITORS OF THE GPIIbIIIa RECEPTOR |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995003820A1 Transgenic, cross-linked hemoglobin |
| 02/09/1995 | DE4428025A1 Inhibitoren der Acyl-Enzym-A-Cholesterin-O-Acyl-Transferase mit therapeutischer Wirksamkeit, ihre Verwendung und sie enthaltende pharmazeutische Zusammensetzungen Inhibitors of acyl-enzyme A: cholesterol O-acyl transferase with therapeutic efficacy, their use and pharmaceutical compositions containing them |
| 02/09/1995 | CA2168261A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | CA2166995A1 Transgenic, cross-linked hemoglobin |
| 02/08/1995 | EP0637451A1 Preparation of blood coagulation factor XIII without viruses |
| 02/08/1995 | EP0637306A1 4-imidomethyl-1- 2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht 2?-antagonists, their preparation and use in therapy |
| 02/08/1995 | EP0637304A1 1-piperazineacetic derivatives as fibrinogen receptor antagonists |
| 02/07/1995 | US5387710 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
| 02/07/1995 | US5387709 Bronchodilator agents, anticoagulants, vasodilation |
| 02/07/1995 | US5387591 Pyrrolidine compounds |
| 02/06/1995 | CA2129374A1 Carbonamides, pharmaceutical compositions containing these compounds and processes for their preparation |
| 02/03/1995 | CA2129155A1 Virus-inactivated factor xa preparation |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003305A1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003068A1 Method for administering hemoglobin |
| 02/02/1995 | WO1995003039A1 N,n,n-trimethylsphingosine derivatives |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2165982A1 N,n,n-trimethylsphingosine derivatives |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/01/1995 | EP0636609A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them |
| 02/01/1995 | EP0636608A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636144A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
| 02/01/1995 | EP0636142A1 Lactam peptides having hle inhibiting activity |
| 02/01/1995 | EP0528997B1 Disulfide derivatives of mercaptoacylamino acids |
| 01/31/1995 | US5385937 Preventing peroxide generation from mercaptan groups and endothelial injury |
| 01/31/1995 | US5385931 Multistage formation of sulfonamides by reaction of esters and acyl halides, nitriding, reduction and sulfonylation to form cardiovascular compounds |
| 01/31/1995 | US5385890 Improved solubility; mixture with polyoxyethylene glycol sorbital alkyl ester |
| 01/31/1995 | CA2129215A1 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| 01/31/1995 | CA1334167C Method of preventing or reducing platelet loss during extra-corporeal circulation using a thromboxane a receptor antagonist |
| 01/26/1995 | WO1995002587A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists |
| 01/26/1995 | WO1995002405A1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 01/26/1995 | WO1995002326A1 Solutions for tissue preservation and bloodless surgery and methods using same |
| 01/26/1995 | CA2167409A1 Solutions for tissue preservation and bloodless surgery and methods using same |
| 01/26/1995 | CA2166974A1 Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists |
| 01/25/1995 | EP0635492A1 Glycoprotein IIb/IIIa antagonists |
| 01/25/1995 | EP0635008A1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
| 01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
| 01/25/1995 | CN1097753A 5-membered heterocycles, processes for preparing them and pharmaceutical compositions containing these compounds |